What is it about?
Patients with early stage lung cancer are increasingly facing decisions about which treatment to undergo. Patients in our study were extremely satisfied with all aspects of their care despite reporting little knowledge about risks or other treatment options, no direct elicitation of worries from providers, and a lack of shared decision making.
Why is it important?
While surgical resection is recommended for most patients with early stage lung cancer according to the National Comprehensive Cancer Network (NCCN) guidelines, stereotactic body radiotherapy (SBRT) is being increasingly utilized. Provider-patient communication regarding risks/benefits of each approach may be a modifiable factor leading to improved patient-centered outcomes.
Read the Original
This page is a summary of: “Even if I Don’t Remember, I Feel Better”. A Qualitative Study of Patients with Early-Stage Non–Small Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy or Surgery, Annals of the American Thoracic Society, August 2016, American Thoracic Society, DOI: 10.1513/annalsats.201602-130oc.
You can read the full text:
The following have contributed to this page